Abstract: TH-PO818
Patient Reported Clinical Symptoms Are Associated with Patient Outcomes
Session Information
- Dialysis: Epidemiology, Outcomes, Clinical Trials - Non-Cardiovascular - I
November 02, 2017 | Location: Hall H, Morial Convention Center
Abstract Time: 10:00 AM - 10:00 AM
Category: Dialysis
- 607 Dialysis: Epidemiology, Outcomes, Clinical Trials - Non-Cardiovascular
Authors
- Maddux, Dugan, Fresenius Medical Care North America, Waltham, Massachusetts, United States
- Han, Hao, Fresenius Medical Care North America, Waltham, Massachusetts, United States
- Larkin, John W., Fresenius Medical Care North America, Waltham, Massachusetts, United States
- Usvyat, Len A., Fresenius Medical Care North America, Waltham, Massachusetts, United States
- van der Sande, Frank, Maastricht University Medical Centre , Maastricht, Netherlands
- Kooman, Jeroen, Maastricht University Medical Centre , Maastricht, Netherlands
- Maddux, Franklin W., Fresenius Medical Care North America, Waltham, Massachusetts, United States
Background
Traditional outcomes-related research on dialysis patients typically focuses on biomarkers such as blood pressure, body size, albumin (alb) and hemoglobin. During dialysis treatment, however, nurse-documented “chairside” patient information is also collected, and majorly includes patients’ symptoms that may have an effect on patients’ clinical outcomes. The association of chairside data with patient outcomes has not been well described. We aim to understand the relationship of “shortness of breath” (SOB), a nurse-reported patient symptom, to patient outcomes.
Methods
We included all patients who initiated dialysis treatment in the network of Fresenius Medical Care North America clinics between Jan 1, 2013 and June 30, 2015. Only patients who survived the first 365 days on dialysis were included. Patient laboratory and treatment parameters including The Kidney Disease Quality of Life (KDQOL) survey were computed as averages of the first year on dialysis. Patient hospitalization outcomes were assessed in year 2 on dialysis. We computed percent of treatments where patients experienced SOB symptoms as determined by either nursing notes or checkbox-based assessment in the electronic health record. A Poisson model using hospital admissions as an outcome was utilized to calculate the association of SOB to hospital admissions.
Results
We analyzed data on 39,594 dialysis patients. In a univariate analysis, we noted that the strongest correlation with percent of treatments with SOB were hospital admission rate (r=0.14, p<0.001), alb level (r=-0.09, p<0.001), KDQOL physical composite score (r=-0.12, p<0.001), and KDQOL symptom problem score (r=-0.11, p<0.001). We also observed that the percent of treatments with SOB was clearly significantly associated with more hospital admissions.
Conclusion
Chairside observation and clinician documentation of patient-reported symptoms may be an important predictor of outcomes in dialysis patients. Additional analyses are needed to understand the association of SOB and other symptoms to patient outcomes.
Funding
- Commercial Support –